© 1997 by European Society of Cardiology
Copyright © 1997, European Society of Cardiology
Effects of 17β-estradiol and progesterone on migration of human monocytic THP-1 cells stimulated by minimally oxidized low-density lipoprotein in vitro
Department of Obstetrics and Gynecology, Nagoya University School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466, Japan
* Corresponding author. Tel.: +81 (52) 744-2261; fax: +81 (52) 744-2268.
Objective: Many epidemiological studies have shown that postmenopausal hormone replacement therapy (HRT) has a beneficial effect on atherosclerotic cardiovascular disease. The aim of this study was to investigate the effects of estrogen and progestin on the migration of monocytes induced by minimally oxidized low-density lipoprotein (m-ox-LDL) in vitro. Methods: Human monocytic THP-1 cells were used for the study. Migration assay was performed using a modified Boyden chamber. Results: The presence of estrogen receptors was determined in THP-1 cells by Western and Northern blot analysis. Although native LDL had no significant effects on the migration of THP-1 cells, m-ox-LDL increased the migration of THP-1 cells in a dose-dependent manner. Although 17β-estradiol (E2, 10–9 
10–6 M) inhibited the 10 µg/ml-induced migration of THP-1 cells in a dose-dependent manner, estrone (E1), estriol (E3) and progesterone (P) had no significant effects. The combination of P (10–910–6 M) did not show any effect on the inhibitory effect of 10–7 M E2. Preincubation of THP-1 cells with the anti-estrogenic agent, tamoxifen (10–6 M), significantly antagonized the inhibitory effect of 10–7 M E2. m-ox-LDL stimulated MCP-1 secretion from THP-1 cells, which was reduced by E2. Anti-human MCP-1 neutralizing antibody inhibited the migration of THP-1 cells stimulated by m-ox-LDL. E2 also inhibited the 10 ng/ml MCP-1-induced migration of THP-1 cells in a dose-dependent manner. Conclusions: These findings suggest that the inhibitory effect of E2 on the migration of monocytes might be one of the factors involved in the decreased incidence of atherosclerotic cardiovascular disease in premenopausal women and postmenopausal HRT.
KEYWORDS Estrogen; Progestin; Monocytes; Minimally oxidized LDL; Migration; MCP-1; Postmenopausal hormone replacement therapy; Atherosclerosis
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  R. Mo, J. Chen, A. Grolleau-Julius, H. S. Murphy, B. C. Richardson, and R. L. Yung Estrogen Regulates CCR Gene Expression and Function in T Lymphocytes J. Immunol., May 15, 2005; 174(10): 6023 - 6029. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.A.L. Bain, M.R. Walters, K.R. Lees, and M.A. Lumsden The effect of HRT on cerebral haemodynamics and cerebral vasomotor reactivity in post-menopausal women Hum. Reprod., October 1, 2004; 19(10): 2411 - 2414. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. K. Bengtsson, E. J. Ryan, D. Giordano, D. M. Magaletti, and E. A. Clark 17{beta}-Estradiol (E2) modulates cytokine and chemokine expression in human monocyte-derived dendritic cells Blood, September 1, 2004; 104(5): 1404 - 1410. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Stork, K. Baumann, C. von Schacky, and P. Angerer The effect of 17{beta}-estradiol on MCP-1 serum levels in postmenopausal women Cardiovasc Res, February 15, 2002; 53(3): 642 - 649. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. K. Dubey and E. K. Jackson Estrogen-induced cardiorenal protection: potential cellular, biochemical, and molecular mechanisms Am J Physiol Renal Physiol, March 1, 2001; 280(3): F365 - F388. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. B. Stefano, P. Cadet, C. Breton, Y. Goumon, V. Prevot, J. P. Dessaint, J.-C. Beauvillain, A. S. Roumier, I. Welters, and M. Salzet Estradiol-stimulated nitric oxide release in human granulocytes is dependent on intracellular calcium transients: evidence of a cell surface estrogen receptor Blood, June 15, 2000; 95(12): 3951 - 3958. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. B. Stefano, V. Prevot, J.-C. Beauvillain, C. Fimiani, I. Welters, P. Cadet, C. Breton, J. Pestel, M. Salzet, and T. V. Bilfinger Estradiol Coupling to Human Monocyte Nitric Oxide Release Is Dependent on Intracellular Calcium Transients: Evidence for an Estrogen Surface Receptor J. Immunol., October 1, 1999; 163(7): 3758 - 3763. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Santanam, R. Shern-Brewer, R. McClatchey, P. Z. Castellano, A. A. Murphy, S. Voelkel, and S. Parthasarathy Estradiol as an antioxidant: incompatible with its physiological concentrations and function J. Lipid Res., November 1, 1998; 39(11): 2111 - 2118. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. Pervin, R. Singh, M. E. Rosenfeld, M. Navab, G. Chaudhuri, and L. Nathan Estradiol Suppresses MCP-1 Expression In Vivo : Implications for Atherosclerosis Arterioscler Thromb Vasc Biol, October 1, 1998; 18(10): 1575 - 1582. [Abstract] [Full Text] [PDF]
|
|